ELI LILLY & Co — Director's Dealing 2012

Jan 11, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2012-01-01

Reporting Person: Ricks David A (SVP and Pres, Lilly Bio-Meds)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2010	Indirect
Common Stock	9936	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee stock option 2/02 (right to buy)	$75.92	2012-02-17	Common Stock (2500)		Direct
Employee stock option 2/03 (right to buy)	$57.85	2013-02-15	Common Stock (5000)		Direct
Employee stock option 2/04 (right to buy)	$73.11	2014-02-14	Common Stock (6300)		Direct
Employee stock option 2/05 (right to buy)	$55.65	2015-02-10	Common Stock (1509)		Direct
Employee stock option 2/06 (right to buy)	$56.18	2016-02-09	Common Stock (4970)		Direct
Restricted Stock Unit	$0.00	2012-12-03	Common Stock (2748)		Direct
Restricted Stock Unit	$0.00	2017-12-03	Common Stock (5496)		Direct